ReviewVaccine: X2024

The cost-effectiveness of COVID-19 vaccination program among age-groups children, adults, and elderly in Europe: A systematic review.

T Untung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.